Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [BUSINESS]
2 clusters · 8 sources · 4 days · First seen · Last updated
Yuhan Corporation healthcare initiatives
Overview
Yuhan Corporation has engaged in multiple efforts to advance healthcare awareness and innovation. The company participated in the International Gaucher Association’s World Gaucher Day campaign, which focused on the theme ‘Equity in Action’ to address global disparities in disease diagnosis and treatment. Alongside these awareness efforts, Yuhan Corp is developing YH35995, an oral drug candidate for Gaucher disease, currently undergoing Phase 1 clinical trials.
Additionally, Yuhan Corporation expanded its long term relationship with Boehringer Ingelheim Korea through a strategic memorandum of understanding. This alliance shifts from a traditional distribution model to a broader collaboration focused on healthcare innovation, digital healthcare, and patient support. The partnership aims to address cardiovascular, renal, and metabolic diseases through clinical exchanges and the introduction of innovative medicines.
Entities
Yuhan Corporation · Kim Yeol-hong · Boehringer Ingelheim · Anna Maria Boyi · International Gaucher Association
Timeline
-
[BUSINESS] 3 sourcesYuhan Corporation and Boehringer Ingelheim sign strategic healthcare partnership
Yuhan Corporation and Boehringer Ingelheim Korea are expanding their 16 year partnership into a strategic alliance focused on digital healthcare, CRM disease innovation, and ecosystem development.
-
[HEALTH] 5 sourcesYuhan Corp joins global campaign to raise awareness for Gaucher disease
Yuhan Corp is participating in the World Gaucher Day campaign to improve global disease awareness while advancing clinical trials for its oral drug candidate, YH35995.
Sources
biz.heraldcorp.com · bosa.co.kr · healthfocus.co.kr · healthmedia.co.kr · hin.company · idsn.co.kr · linkmagazine.nl · localsegye.co.kr